Total Payments
$97,902
2024 Payments
$4,668
Companies
90
Transactions
1,924
Medicare Patients
35,961
Medicare Billing
$16.1M
Payment Breakdown by Category
Other$63,392 (64.8%)
Food & Beverage$32,271 (33.0%)
Travel$1,373 (1.4%)
Education$616.28 (0.6%)
Consulting$250.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,900 | 19 | 58.1% |
| Food and Beverage | $32,271 | 1,875 | 33.0% |
| Honoraria | $6,492 | 4 | 6.6% |
| Travel and Lodging | $1,373 | 3 | 1.4% |
| Education | $616.28 | 22 | 0.6% |
| Consulting Fee | $250.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $54,882 | 117 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $8,423 | 227 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $6,737 | 11 | $0 (2024) |
| Amgen Inc. | $2,399 | 133 | $0 (2023) |
| Genentech USA, Inc. | $2,223 | 175 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,811 | 91 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,531 | 96 | $0 (2024) |
| Celgene Corporation | $1,486 | 102 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,415 | 85 | $0 (2024) |
| Janssen Biotech, Inc. | $1,357 | 81 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,668 | 221 | PFIZER INC. ($411.93) |
| 2023 | $4,862 | 230 | Seagen Inc. ($399.70) |
| 2022 | $4,032 | 211 | Amgen Inc. ($307.60) |
| 2021 | $7,033 | 217 | Pharmacosmos Therapeutics Inc. ($3,194) |
| 2020 | $7,256 | 217 | Pharmacosmos Therapeutics Inc. ($3,518) |
| 2019 | $3,879 | 277 | E.R. Squibb & Sons, L.L.C. ($694.15) |
| 2018 | $20,332 | 282 | PFIZER INC. ($16,797) |
| 2017 | $45,841 | 269 | PFIZER INC. ($37,205) |
All Payment Transactions
1,924 individual payment records from CMS Open Payments — Page 1 of 77
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Oncology | ||||||
| 12/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Oncology | ||||||
| 12/23/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Oncology | ||||||
| 12/20/2024 | PFIZER INC. | IBRANCE (Drug), XTANDI, TUKYSA | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Genentech USA, Inc. | Tecentriq Hybreza (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: BioOncology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Oncology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.05 | General |
| 12/13/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/13/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Genentech USA, Inc. | Itovebi (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: BioOncology | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: Hematology | ||||||
| 12/02/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $1.04 | General |
| Category: Hematology | ||||||
| 11/27/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: BioOncology | ||||||
| 11/24/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $36.82 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Oncology | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 77 | 10,530 | 250,263 | $15.1M | $4.3M |
| 2022 | 82 | 10,224 | 335,307 | $16.4M | $4.4M |
| 2021 | 75 | 8,148 | 270,383 | $10.1M | $3.1M |
| 2020 | 71 | 7,059 | 257,854 | $13.3M | $4.3M |
Total Patients
35,961
Total Services
1,113,807
Medicare Billing
$16.1M
Procedure Codes
305
All Medicare Procedures & Services
305 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 16 | 22,200 | $2.4M | $959,847 | 39.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 148 | 33,960 | $1.4M | $624,087 | 44.3% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2023 | 20 | 15,480 | $2.3M | $584,377 | 25.6% |
| J9299 | Injection, nivolumab, 1 mg | Office | 2023 | 12 | 22,500 | $1.2M | $532,368 | 44.6% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 21 | 9,660 | $1.1M | $345,451 | 32.2% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 107 | 14,800 | $891,700 | $244,913 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 753 | 1,790 | $447,500 | $154,888 | 34.6% |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | Office | 2023 | 13 | 5,570 | $863,350 | $138,485 | 16.0% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2023 | 27 | 1,500 | $1.2M | $130,638 | 10.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 141 | 871 | $421,564 | $82,048 | 19.5% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 12 | 17,400 | $182,700 | $40,662 | 22.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 922 | 3,189 | $239,175 | $32,843 | 13.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 149 | 243 | $83,835 | $31,103 | 37.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 938 | 3,911 | $293,325 | $29,414 | 10.0% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 35 | 20,670 | $96,322 | $28,212 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 891 | 3,224 | $96,720 | $26,659 | 27.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 191 | 501 | $65,130 | $22,502 | 34.5% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 16 | 91 | $66,700 | $16,252 | 24.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 537 | 1,197 | $101,745 | $15,866 | 15.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 95 | 95 | $47,130 | $15,041 | 31.9% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 27 | 36,210 | $108,630 | $13,971 | 12.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 299 | 1,352 | $101,400 | $13,786 | 13.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 444 | 852 | $65,604 | $12,467 | 19.0% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 26 | 722 | $54,150 | $11,995 | 22.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 96 | 548 | $98,640 | $11,657 | 11.8% |
About Dr. Daniel Ibach, MD
Dr. Daniel Ibach, MD is a Hematology & Oncology healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619947876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Ibach, MD has received a total of $97,902 in payments from pharmaceutical and medical device companies, with $4,668 received in 2024. These payments were reported across 1,924 transactions from 90 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,900).
As a Medicare-enrolled provider, Ibach has provided services to 35,961 Medicare beneficiaries, totaling 1,113,807 services with total Medicare billing of $16.1M. Data is available for 4 years (2020–2023), covering 305 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Knoxville, TN
- Active Since 01/23/2006
- Last Updated 03/02/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1619947876
Products in Payments
- ELIQUIS (Drug) $59,775
- Monoferric (Drug) $6,712
- OPDIVO (Biological) $2,029
- KEYTRUDA (Biological) $1,316
- Lenvima (Drug) $843.66
- LIBTAYO (Biological) $827.87
- IMBRUVICA (Drug) $750.38
- DARZALEX (Biological) $652.26
- Revlimid (Drug) $599.70
- XPOVIO (Drug) $577.00
- JAKAFI (Drug) $572.74
- ADCETRIS (Biological) $561.00
- SARCLISA (Biological) $522.91
- KISQALI (Drug) $510.34
- Kyprolis (Biological) $506.10
- TECENTRIQ (Biological) $502.89
- ZEJULA (Drug) $499.94
- TUKYSA (Drug) $435.52
- Trodelvy (Drug) $423.38
- Pomalyst (Drug) $420.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Knoxville
Raymond Brig, Md, MD
Hematology & Oncology — Payments: $112,556
Hematology & Oncology $112,556
Ross Kerns, M.d, M.D
Hematology & Oncology — Payments: $46,740
Hematology & Oncology $46,740
Dr. Arun Kumar, Md, MD
Hematology & Oncology — Payments: $36,433
Hematology & Oncology $36,433
Nathan Schrock, Md, MD
Hematology & Oncology — Payments: $28,323
Hematology & Oncology $28,323
Tracy Dobbs, Md, MD
Hematology & Oncology — Payments: $28,019
Hematology & Oncology $28,019
Robert Schumaker, Md, MD
Hematology & Oncology — Payments: $25,485
Hematology & Oncology $25,485